U.S. Markets closed

BioHarvest Sciences Inc. (BHSC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.33500.0000 (0.00%)
At close: 3:59PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3350
Bid0.3200 x N/A
Ask0.3550 x N/A
Day's Range0.3300 - 0.3350
52 Week Range0.1200 - 0.7100
Avg. Volume79,000
Market Cap144.519M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0390
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    BioHarvest Sciences Inc. Increases Its VINIA 2021 Annual Sales Orders Forecast for Israel by 15%

    Vancouver, Canada, and Rehovot, Israel--(Newsfile Corp. - October 13, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") today announces an update to its forecast of 2021 annual sales orders for VINIA® in Israel. The Company has increased its 2021 sales orders forecast for Israel to US$ 1.6M - US$ 1.7M from the previous forecast of US$ 1.3M - US$ 1.5M announced in March 2021. The continued adoption of VINIA® ...

  • Newsfile

    BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event October 14, 2021, at 2:00pm E.T.

    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 12, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, October 14, 2021, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time).BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a report on all major 2021 priorities, including a detailed performan

  • CNW Group

    BioHarvest Sciences Inc. Reports Strong Q3 2021 Results on all of the Company's Activities

    BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) today announced another strong quarter, fueled by strong growth of VINIA® sales in Israel and the U.S. Q3 VINIA® pilot sales revenues were USD 688K representing 44% growth over Q2 2021 and 1,198% growth over Q3 2020.